Citation: | Cheng Si Gen , Luo Zhi Gang , Liu De Hua , Yang Shu . 幽门螺杆菌清除治疗中甲硝唑、克拉霉素、阿莫西林的耐药性[J]. Journal of Kunming Medical University, 2018, 39(04): 104-108. |
目的 探究幽门螺杆菌 (H.pylori) 对不同种抗菌药物耐药问题的研究.方法 选取云南省昆明市第一人民医院2015年8月至2017年4月接诊出现消化道症状且经胃镜检查确诊幽门螺杆菌感染的240例患者为研究对象, 按照临床给药不同分为A、B、C 3组, A组80例患者给予 (埃索美拉唑+甲硝唑+左氧氟沙星) 治疗, B组80例患者给予 (埃索美拉唑+克拉霉素+左氧氟沙星) 治疗, C组80例患者给予 (埃索美拉唑+阿莫西林+左氧氟沙星) 治疗, 3组患者治疗10 d后通过胃镜从患者胃窦取2块胃粘膜组织, 进行幽门螺杆菌培养及E-test测试, 观察幽门螺杆菌感染个体对不同种抗菌药物的耐药性、临床治疗效果以及不良反应发生情况.结果 A组甲硝唑耐药率为51.25% (54/80) , 明显高于B组、C组, C组临床治疗总有效率为93.50%, 明显高于B组与A组, C组不良反应发生率为3.75%, 明显低于B组、A组, 各项数据差异有统计学意义 (P<0.05) .结论 清除幽门螺杆菌治疗中, 甲硝唑耐药性较高, 阿莫西林耐药性最低.
[1]胡伏莲.中国幽门螺杆菌耐药研究现状[J].胃肠病学和肝病学杂志, 2008, 17 (7) :517-518.
|
|
[2] |
[2]MASAOKA T, SUZUKL H, KURUBAYASHI K, et al.Could frameshiftmutations in the frx A and rdx A genes of Helicobacter pylori bea marker or metronidazole resistance[J].Aliment Pharmacol Ther, 2006, 2 (1) :81-87.
|
[3] |
[3]SEPULVEDA A R, COELHO L G.Helicobacter pylori and gastricmalignancies[J].Helicobacter, 2002, 7 (1) :37-42.
|
[4] |
[4]YAHAV J, SHMUELY H, NIV Y.In vitro activity of levofloxacinagainst Helicobacter pylori isolates from patients after treatment failure[J].Diagn Microbiol Infect Dis, 2006, 55 (1) :81-83.
|
[5] |
[5]BRANCA G, SPANU T, CAMMAROTA G, et al.High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates frompatients after failure of therapy[J].J Antimicrob Chemother, 2004, 24 (5) :433-438.
|
[6]侯中英, 崔小强, 姜曼, 等.幽门螺杆菌临床治疗中抗菌药物耐药现状及其耐药机制[J/CD].中华实验和临床感染病杂志:电子版, 2014, 10 (4) :115-117.
|
|
[7] |
[7]索日娜, 赵丽萍.难治性胃炎患者幽门螺杆菌耐药性分析[J].解放军预防医学杂志, 2017, 35 (2) :162-164.
|
[8] |
[8]姜葵, 张建中, 潘国中.幽门螺杆菌耐药性检测[J].中国人兽共患病杂志, 2000, 16 (6) :76-78.
|
[9] |
[9]虎月燕, 周曾芬, 南琼, 等.云南省三个民族人群螺旋杆菌甲硝唑耐药调查[J].中华流行病学杂志, 2004, 25 (11) :986-988.
|
[10]丁玲, 胡毅.江津地区幽门螺杆菌耐药情况分析[J].胃肠病学和肝病学杂志, 2013, 22 (3) :235-236.
|
|
[11] |
[11]KIMJ M, KIMJ S, JUN H C, et al.Distribution of antibiotic MICsfor helicobacter pylori strains over a 16-Year period in patients from seoul, the republic oF Korea[J].Antimicrob Agents Chemother, 2004, 48 (12) :4843-4847.
|
[12] |
[12]MOORE J M, SALAMA N R.Mutational Analysis of Metronidazole Resistance in Helicobacter pylori[J].Antimicrob Agents Chemother, 2005, 49 (3) :1236-1237.
|
[13]中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组, 刘文忠, 谢勇, 等.第四次全国幽门螺杆菌感染处理共识报告[J].中华消化杂志, 2012, 32 (10) :655-661.
|
|
[14]刘改芳, 徐华州, 张玉贞, 等.幽门螺杆菌临床分离株耐药性研究[J].中国实用内科杂志, 2005, 25 (2) :180-131.
|
|
[15]张万岱, 胡伏莲, 萧树东, 等.中国自然人群幽门螺杆菌感染的流行病学调查[J].现代消化及介入诊疗, 2010, 15 (5) :265-270.
|
|
[16]闫书婷, 张锦华, 庄剑波, 等.兰州市幽门螺杆菌临床分离株耐药性分析[J].中国公共卫生, 2010, 26 (6) :774-775.
|
|
[17] |
[17]刘雪芳, 马岚青.幽门螺杆菌对克拉霉素、甲硝唑、左氧氟沙星耐药的研究进展[J].胃肠病学和肝病学杂志, 2016, 25 (1) :101-104.
|
[18]王婕鹏.探究幽门螺杆菌高耐药流行现状及应对[J].中国卫生产业, 2014, 14 (13) :188-190.
|
|
[19]王振清.幽门螺杆菌对抗生素耐药研究进展[J].内蒙古中医药, 2014, 33 (16) :110-111.
|
|
[20]代薇, 罗娟.幽门螺杆菌耐药情况分析[J].昆明医科大学学报, 2014, 35 (4) :162-163.
|
[1] | Xuelin ZHANG, Lu LIU, Yanzhi CHEN, Caijun ZHA, Yanli LI. The Distribution and Drug Resistance of Pathogenic Bacteria in Respiratory Tract Infections in Children from 2019 to 2022. Journal of Kunming Medical University, 2024, 45(1): 149-155. doi: 10.12259/j.issn.2095-610X.S20240125 |
[2] | Xiaoqing ZHAO, Jiaxin XIAO, Yong LIN, Jianfeng ZHANG, Wenhui WANG, Wenjie ZHANG. Effects of Different Virulence Types of Helicobacter Pylori on Gastric Micro-environment. Journal of Kunming Medical University, 2024, 45(2): 148-152. doi: 10.12259/j.issn.2095-610X.S20240221 |
[3] | Ying ZHANG, Hong GAO, Cuixiang ZHANG, Zeying CHEN, Hongqun ZOU, Liqiong LI, Jupin YANG, Yuexin HU. Helicobacter Pylori Infection in Children and its Correlation with Iron Deficiency Anemia. Journal of Kunming Medical University, 2022, 43(4): 103-106. doi: 10.12259/j.issn.2095-610X.S20220418 |
[4] | Lianyong CHEN, Haohao RU, Xing YANG, Shuangqun YAN, Tao CHEN, Qinxuan NI, Lin XU. Characteristics of katG and inhA Gene Mutations in INH-Resistant Mycobacterium Tuberculosis in Yunnan Province. Journal of Kunming Medical University, 2022, 43(8): 28-33. doi: 10.12259/j.issn.2095-610X.S20220803 |
[5] | Xueting YANG, Huifeng ZHANG. Evaluation of Drug Utilization in the Infected Patients with ESBLs Produced by Enterobacteriaceaein. Journal of Kunming Medical University, 2022, 43(6): 74-78. doi: 10.12259/j.issn.2095-610X.S20220621 |
[6] | Jinyi GU, Deyao DENG, Wenli YUAN, Qiuping YANG, Jianmei SONG, Yanjun SHEN, Yuanyuan GUO, Hongyun XU. Clinical Distribution and Drug Resistance Analysis of Acineto Bacterbaumannii from 2014 to 2020. Journal of Kunming Medical University, 2022, 43(5): 83-87. doi: 10.12259/j.issn.2095-610X.S20220504 |
[7] | Pu-mei CUI, Tai-fang CHEN, Chao CHEN, Yong-mei LIANG, Yue XU. Correlation Analysis of Antimicrobial Use and Common Bacterial Resistance in a Hospital in Yunnan From 2016 to 2019. Journal of Kunming Medical University, 2021, 42(11): 140-147. doi: 10.12259/j.issn.2095-610X.S20211127 |
[8] | Li Yao . Correlation of Oral Lichen Planus with Helicobacter pylori in Kunming. Journal of Kunming Medical University, |
[9] | Wang Li Kun . . Journal of Kunming Medical University, |
[10] | Zhao Xiao Li . . Journal of Kunming Medical University, |
[11] | Fu Yuan Chun . . Journal of Kunming Medical University, |
[12] | Wang Qiang . . Journal of Kunming Medical University, |
[13] | Qi Yan Wei . 云南省HIV/AIDS患者下呼吸道感染病原菌分布及耐药分析. Journal of Kunming Medical University, |
[14] | Wang Li Kun . . Journal of Kunming Medical University, |
[15] | Chen Lian Yong . . Journal of Kunming Medical University, |
[16] | Dai Wei . . Journal of Kunming Medical University, |
[17] | Mao Jian . . Journal of Kunming Medical University, |
[18] | Li Yu Xiao . . Journal of Kunming Medical University, |
[19] | Zhou Shi Qiao . . Journal of Kunming Medical University, |
[20] | Cao Jia . Hp Infection and HLA-DR Antigen Expression in Peripheral Blood Lymphocytes and Monocytes among Family Members of Children with Recurrent Abdominal Pain. Journal of Kunming Medical University, |